Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-28 @ 12:12 AM
Study NCT ID:
NCT05248334
Status:
UNKNOWN
Last Update Posted:
2022-08-12
First Post:
2022-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy
Sponsor:
Tianjin Medical University Eye Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-07
First Submit QC Date:
None
Study First Post Date:
2022-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-11
Last Update Post Date:
2022-08-12
Last Update Post Date Type:
ACTUAL